Related references
Note: Only part of the references are listed.Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
S. T. Martin et al.
BRITISH JOURNAL OF SURGERY (2012)
Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Laurence Albiges et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Testicular Cancer Clinical Practice Guidelines in Oncology
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Modified Surgical Technique for the Management of Renal Cell Carcinoma With Level I or II Tumor Thrombus
Michael A. Gorin et al.
UROLOGY (2012)
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
T. Powles et al.
ANNALS OF ONCOLOGY (2011)
Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?
Brian Shuch et al.
BJU INTERNATIONAL (2011)
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients
Xiangnan Kong et al.
EUROPEAN JOURNAL OF CANCER (2011)
The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus
Nicholas G. Cost et al.
EUROPEAN UROLOGY (2011)
Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
Katherine M. Krajewski et al.
EUROPEAN UROLOGY (2011)
Safety Issues and Rationale for Neoadjuvant Approaches in Renal Cell Carcinoma
Thomas Bessede et al.
EUROPEAN UROLOGY (2011)
Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma
E. Jason Abel et al.
EUROPEAN UROLOGY (2011)
Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma
Brian F. Chapin et al.
EUROPEAN UROLOGY (2011)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Giuseppe Di Lorenzo et al.
EUROPEAN UROLOGY (2011)
The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
Thomas Powles et al.
EUROPEAN UROLOGY (2011)
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Hendrik Van Poppel et al.
EUROPEAN UROLOGY (2011)
Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
Jose A. Karam et al.
JOURNAL OF UROLOGY (2011)
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients
C. Seidel et al.
WORLD JOURNAL OF UROLOGY (2011)
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib
Axel Bex et al.
ACTA ONCOLOGICA (2010)
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate
Chandrajit P. Raut et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery
Jonathan L. Silberstein et al.
BJU INTERNATIONAL (2010)
Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non-Clear Cell Renal Cell Carcinoma
Oscar Rodriguez Faba et al.
EUROPEAN UROLOGY (2010)
Integrating Surgery with Targeted Therapies for Renal Cell Carcinoma: Current Evidence and Ongoing Trials
Axel Bex et al.
EUROPEAN UROLOGY (2010)
Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors
Aneesh Srivastava et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2010)
Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
C. Lance Cowey et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nephrectomy Induced Chronic Renal Insufficiency is Associated With Increased Risk of Cardiovascular Death and Death From Any Cause in Patients With Localized cT1b Renal Masses
Christopher J. Weight et al.
JOURNAL OF UROLOGY (2010)
Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
Nicholas J. Hellenthal et al.
JOURNAL OF UROLOGY (2010)
Complete Histologic Remission after Sunitinib Neoadjuvant Therapy in T3b Renal Cell Carcinoma
Gregoire Robert et al.
EUROPEAN UROLOGY (2009)
Treatment with Sunitinib Enabled Complete Resection of Massive Lymphadenopathy not Previously Amenable to Excision in a Patient with Renal Cell Carcinoma
Jean-Jacques Patard et al.
EUROPEAN UROLOGY (2009)
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma
Eric Jonasch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Surgical Resection of Renal Cell Carcinoma After Targeted Therapy
Anil A. Thomas et al.
JOURNAL OF UROLOGY (2009)
Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
Anil A. Thomas et al.
JOURNAL OF UROLOGY (2009)
Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib
Lauren C. Harshman et al.
NATURE REVIEWS UROLOGY (2009)
Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus
Laetitia Albano et al.
TRANSPLANTATION (2009)
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery
Axel Bex et al.
WORLD JOURNAL OF UROLOGY (2009)
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm
Brian Shuch et al.
BJU INTERNATIONAL (2008)
Renal and cardiovascular morbidity after partial or radical nephrectomy
David C. Miller et al.
CANCER (2008)
Sunitinib for treatment of advanced renal cell cancer: Primary tumor response
Astrid A. M. Van der Veldt et al.
CLINICAL CANCER RESEARCH (2008)
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi
Pierre I. Karakiewicz et al.
EUROPEAN UROLOGY (2008)
Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases
Susan B. Kesmodel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma
Vitaly Margulis et al.
JOURNAL OF UROLOGY (2008)
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy
R. Houston Thompson et al.
JOURNAL OF UROLOGY (2008)
Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy
Franco Di Silverio et al.
UROLOGIA INTERNATIONALIS (2008)
Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma
Vitaly Margulis et al.
BJU INTERNATIONAL (2007)
Prognostic factors for renal cell carcinoma with tumor thrombus extension
Tobias Klatte et al.
JOURNAL OF UROLOGY (2007)
Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus
Erica H. Lambert et al.
UROLOGY (2007)
Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: Combining surgery and systemic therapies to improve patient outcome
Christopher G. Wood
CLINICAL CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Post-kidney transplant surgical complications under new immunosuppressive regimens
F. J. Burgos et al.
TRANSPLANTATION PROCEEDINGS (2006)
Chronic kidney disease after nephrectorny in patients with renal cortical turnours: a retrospective cohort study
William C. Huang et al.
LANCET ONCOLOGY (2006)
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
S Kuppahally et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
ML Blute et al.
BJU INTERNATIONAL (2004)
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience
JJ Patard et al.
JOURNAL OF UROLOGY (2004)
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients
SM Flechner et al.
TRANSPLANTATION (2003)
Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation
JF Valente et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study
C Troppmann et al.
TRANSPLANTATION (2003)
Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation
TR Howdieshell et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Surgical management of renal tumors 4 cm. or less in a contemporary cohort
CT Lee et al.
JOURNAL OF UROLOGY (2000)
Share Paper
